Product Images Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human)

This is a table showing the Virus Reduction Factor achieved during different production steps for both enveloped and non-enveloped viruses. Some of the viruses listed include HIV-1, HAV, and PPV. The S/D Treatment step achieved the highest Virus Reduction Factor for enveloped viruses, while Ton-Exchange and Chromatography were also effective. Non-enveloped viruses were more difficult to eliminate, with TDH Treatment achieving the highest reduction factor. A Global Reduction Factor was also calculated for each virus type, with some achieving above 1000 reduction.*

This is a description of a medication called wilate 500U which is administered via intravenous injection. It is a human coagulation factor complex comprised of von Willebrand factor and coagulation factor VIII. The medication has been treated with solvent detergent and heat. The package contains a powder which must be reconstituted with a supplied diluent prior to injection. The medication does not contain any preservatives and has a maximum protein content of 75 mg. The product comes in a single-use vial and must be stored according to the instructions. The National Drug Code (NDC) for this product is 67467-152.01.*

This is a description of a pharmaceutical product for intravenous injection. It includes von Willebrand Factor/ESEE5 (2g) and Coagulation Factor VI Complex (Human) (52 Sl). It also mentions that it is for prescription only and should be reconstituted with the supplied diluent before injection. The product has a total protein content of up to 15.0 my and is manufactured by Eretmausa. There is no available information on how to store it.*